Medical News

RSS

Drop in abortion demonstrates AUL efforts to protect women through commonsense regulations

Americans United for Life President and CEO Dr. Charmaine Yoest called the news of a historic 5% drop in the abortion rate, released by the Centers for Disease Control on the eve of Thanksgiving, "a real cause for giving thanks." Nevertheless, the pro-life leader noted that reporting on the new data has not included a more somber data-point: the number of abortion-related maternal fatalities doubled in 2008, the most recent year data is available.

23 Nov 2012

Well-characterised population cohorts important for clinical decision making

Clinicians are being urged to ask about a patient's history of falls as new research shows that the information is valuable in determining their future risk of fracture.

23 Nov 2012

CPhI's Polymorphism 2012 annual conference to take place in December

CPhI's annual conference, Polymorphism 2012, is a two-day strategic meet taking place from 19-20 December at Hilton International Airport, Mumbai, India. This event has received a lot of interest from the pharma industry as it focuses on a very technical and important subject of polymorphism studies that poses challenges to this industry and excellence in this area is vital for this sector's continued growth.

23 Nov 2012

Lymphopenia driven diseases and the orphan drug industry: an interview with Damian Marron, CEO of Cytheris

Lymphopenia is when you lack the T cells of your immune system. T cells are very important for controlling infection. Probably the most known cause of lymphopenia is HIV.

23 Nov 2012

Osteoporosis medication Aclasta now available on Canadian public drug plans

Osteoporosis Canada congratulates the Ontario government, the New Brunswick government, the Saskatchewan government and the British Columbia government for providing access to a new osteoporosis medication. Aclasta (zoledronic acid) is now available on public and private drug plans in Ontario, BC, SK, and NB meaning Canadians at high risk for fractures have access to increased treatment options.

23 Nov 2012

Researchers trace specific paths of chandelier cells during development into the cerebral cortex

The cerebral cortex of the human brain has been called "the crowning achievement of evolution." Ironically, it is so complex that even our greatest minds and most sophisticated science are only now beginning to understand how it organizes itself in early development, and how its many cell types function together as circuits.

23 Nov 2012

Research reveals surprisingly complex protein-coding capacity of human cytomegalovirus

New findings reveal the surprisingly complex protein-coding capacity of the human cytomegalovirus, or HCMV, and provide the first steps toward understanding how the virus manipulates human cells during infection. The genome of the HCMV was first sequenced over 20 years ago, but researchers have now investigated the proteome-the complete set of expressed proteins-of this common pathogen as well.

23 Nov 2012

Medworxx third quarter revenue increases 85.2% to $2,084,962

Medworxx Solutions Inc. announced today that it has filed with the Canadian securities authorities its Interim Consolidated Financial Statements (Unaudited), and Management's Discussion and Analysis report for the three and nine month interim periods ended September 30, 2012.

23 Nov 2012

Major advance in understanding how flu viruses replicate within infected cells

Scientists at The Scripps Research Institute (TSRI) have made a major advance in understanding how flu viruses replicate within infected cells. The researchers used cutting-edge molecular biology and electron-microscopy techniques to "see" one of influenza's essential protein complexes in unprecedented detail. The images generated in the study show flu virus proteins in the act of self-replication, highlighting the virus's vulnerabilities that are sure to be of interest to drug developers.

23 Nov 2012

Allon Files Preliminary Shelf Prospectus

Allon Therapeutics Inc. has filed a preliminary short form base shelf prospectus with the securities commissions in each province and territory of Canada (other than Quebec).

23 Nov 2012

Unacceptable levels of asbestos leads to closure of Welsh high school

A specialist industrial disease lawyer has said that the closure of a Welsh high school after ten times more than acceptable levels of asbestos were found comes as no surprise, adding that the hidden danger of asbestos in our schools has been known for years.

23 Nov 2012

People worried about catching infections in public transport during flu season

As flu season gets underway, public transport such as buses, trains and subway trains head the list of places where people worry about catching viruses and infections, according to new research by Microban.

23 Nov 2012

Collaborative research on fruits that may help improve vascular health

Scientists at the University of Warwick and consumer goods manufacturer Unilever are joining forces to identify whether the nutrients in everyday fruit and vegetables could help to improve people's cardiovascular health and protect them from Type-2 diabetes.

23 Nov 2012

Word recognition patterns change as people grow older

Unique research into eye-movements of young and old people while reading discovers that word recognition patterns change as we grow older

23 Nov 2012

Behavioural support programme to make TB patients quit smoking receives BUPA Foundation prize

The BUPA Foundation has awarded a high commendation prize for research led by the University of York into effective ways of helping tuberculosis patients in Pakistan to give up smoking.

23 Nov 2012

UPC teams conduct research in biomedical engineering to improve people's health

Systems to improve patient rehabilitation, methods that help detect diseases, and smart biomaterials for optimising treatments—scientific advances in the field of biomedical engineering are unstoppable. A number of leading UPC teams are carrying out research aimed at harnessing technology to improve people's health.

23 Nov 2012

Researchers characterize novel lysosomal PQ protein linked to cystinosis

Researchers at the Université Paris Descartes/CNRS and the Université libre de Bruxelles have made a major breakthrough in the study of cystinosis, a genetic disease that can lead to serious disorders, notably fatal kidney failure.

23 Nov 2012

Advances in genomic techniques help understand cancer at cellular and molecular level

Cancer is a complex disease and only thanks to advances in genomic techniques have researchers begun to understand, at a cellular and molecular level, the mechanisms which are disrupted in cancer cells. This knowledge is a key prerequisite for developing effective treatment strategies.

23 Nov 2012

NICE recommends Bispectral Index EEG-based monitor for measuring depth of anaesthesia

Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced that the UK-based National Institute for Health and Clinical Excellence (NICE) recommends the use of electroencephalography (EEG)-based monitors, specifically the Bispectral Index (BIS) monitor, as an option for measuring depth of anaesthesia.

23 Nov 2012

Medication reduces risk of criminal behaviour in people with ADHD

Criminal behaviour in people with ADHD (attention deficit hyperactivity disorder) dropped sharply during periods when they were on medication, according to a new extensive registry study conducted at Karolinska Institutet in Sweden. The study that contained of over 25,000 individuals is published in the New England Journal of Medicine (NEJM).

23 Nov 2012